IQVIA Holdings is a healthcare information and clinical research company based in the United States. It runs clinical trials and related development work for pharmaceutical and biotechnology companies, and it supplies data, analytics and software that help those customers understand diseases, treatments and patient populations. Its services also support life-sciences firms with consulting and technology for commercial operations, serving clients across the healthcare and life-sciences industries in many countries.
On this site IQVIA Holdings Inc. appears as a stock on the London Exchange (UK), code 0JDM, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
The first paragraph was written with AI from general knowledge about the company and checked automatically; the second comes from our own data. It can contain mistakes: check the company's own website and filings before relying on it.
Market X-Ray · price-based
Strong price profile
Ranks #508 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
91/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average27.8%
From 52-week high-2.9%
MomentumStrong
94/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return31.6%
6-month return50.9%
Risk (lower is better)Weak
39/100
Volatile, with deep drawdowns.
See the numbers →
Volatility (1 year)39.6%
Worst drawdown (1 year)-36.7%
LiquidityWeak
47/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.60M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 150.00 – 278.83Daily closes, split-adjusted
Signals
50-day average260.65
200-day average207.52
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)9.81
Technical summary
Daily
Strongly bullish
11 bullish · 4 neutral · 0 bearish
Weekly
Strongly bullish
6 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
1 bullish · 0 neutral · 0 bearish
Moving averages (daily)
SMA 10
262.2
Bullish
EMA 10
263.8
Bullish
SMA 20
264.9
Bullish
EMA 20
263.6
Bullish
SMA 50
260.7
Bullish
EMA 50
255.3
Bullish
SMA 100
230.5
Bullish
EMA 100
238.3
Bullish
SMA 200
207.5
Bullish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
52.75
Neutral
MACD (12, 26)
0.99
Bullish
Momentum (12)
1.98
Bullish
Stochastic %K (14)
55.60
Neutral
Williams %R (14)
-44.40
Neutral
CCI (20)
29.93
Neutral
Pivot points (classic, last session)
S3
250.4
S2
256.8
S1
261.0
Pivot
267.3
R1
271.5
R2
277.9
R3
282.1
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.